CSPC Innovation Pharmaceutical Co., Ltd.
300765.SZFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
277
Cost of Revenue
162
Gross Profit
116
Gross Margin
41.7%
Operating Income
-31
Operating Margin
-11.0%
Net Income
8
Net Margin
2.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-8
EBITDA Margin
-3.0%
2023
12/31/2023
Revenue
355
Cost of Revenue
194
Gross Profit
162
Gross Margin
45.5%
Operating Income
37
Operating Margin
10.3%
Net Income
61
Net Margin
17.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
43
EBITDA Margin
12.2%
2022
12/31/2022
Revenue
368
Cost of Revenue
209
Gross Profit
159
Gross Margin
43.2%
Operating Income
120
Operating Margin
32.6%
Net Income
102
Net Margin
27.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
115
EBITDA Margin
31.2%
2021
12/31/2021
Revenue
259
Cost of Revenue
146
Gross Profit
113
Gross Margin
43.6%
Operating Income
68
Operating Margin
26.3%
Net Income
55
Net Margin
21.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
71
EBITDA Margin
27.3%
2020
12/31/2020
Revenue
184
Cost of Revenue
82
Gross Profit
103
Gross Margin
55.6%
Operating Income
50
Operating Margin
27.3%
Net Income
42
Net Margin
22.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
56
EBITDA Margin
30.2%